Literature DB >> 12567177

Prevalence of and risk factors for HIV infection in individuals testing for HIV at counseling centers in Brazil.

Nêmora Tregnago Barcellos1, Sandra Costa Fuchs, Flávio Danni Fuchs.   

Abstract

BACKGROUND: Risk factors for HIV infection have been scarcely studied in developing countries. GOAL: The goal was to examine the seroprevalence and the risk factors for HIV infection among individuals submitting to voluntary and anonymous testing at counseling and testing centers in Porto Alegre, Brazil. STUDY
DESIGN: In this cross-sectional study HIV infection was diagnosed by enzyme-linked immunosorbent assays (ELISAs) and indirect immunofluorescence. Risk factors for HIV infection were investigated and fitted to logistic regression models according to a hierarchical framework.
RESULTS: The overall prevalence of HIV infection was 11.9%. It was greater among homosexual men, individuals with an HIV-positive partner, and intravenous cocaine users. The factors independently associated with risk for HIV infection were: history of detention, homosexual or bisexual orientation, positive VDRL, sex with male prostitutes, HIV-positive sex partner, sex with injectable drug user (IDU), use of cocaine, and sharing needles or syringes.
CONCLUSION: A high prevalence of HIV infection among individuals attending anonymous testing centers was related to sexual behavior and IDU. Other risk factors might be just proxies of true risk behaviors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12567177     DOI: 10.1097/00007435-200302000-00014

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

1.  Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.

Authors:  Fernando H Wolff; Sandra C Fuchs; Nêmora N T Barcellos; Paulo Ricardo de Alencastro; Maria Letícia R Ikeda; Ajácio B M Brandão; Maicon Falavigna; Flávio D Fuchs
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

Review 2.  HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: a systematic review and meta-analysis.

Authors:  Monica Malta; Monica M F Magnanini; Maeve B Mello; Ana Roberta P Pascom; Yohana Linhares; Francisco I Bastos
Journal:  BMC Public Health       Date:  2010-06-07       Impact factor: 3.295

3.  People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study.

Authors:  Paulo R Alencastro; Nemora T Barcellos; Fernando H Wolff; Maria Letícia R Ikeda; Fabiana Schuelter-Trevisol; Ajácio B M Brandão; Sandra C Fuchs
Journal:  BMC Res Notes       Date:  2017-01-13

4.  Epidemiological and Molecular Characteristics of HIV-1 Infection in a Sample of Men Who Have Sex With Men in Brazil: Phylogeography of Major Subtype B and F1 Transmission Clusters.

Authors:  Ágabo Macêdo da Costa E Silva; Mônica Nogueira da Guarda Reis; Thaís Augusto Marinho; Nara Rúbia de Freitas; Sheila Araújo Teles; Márcia Alves Dias de Matos; Megmar Aparecida Dos Santos Carneiro; Gonzalo Bello; Mariane Martins Araújo Stefani; Regina Maria Bringel Martins
Journal:  Front Microbiol       Date:  2020-11-27       Impact factor: 5.640

5.  Logistic model for determining factors associated with HIV infection among blood donor candidates at the Fundação HEMOPE.

Authors:  Niedja Maristone Barreto Queiroz; Divaldo de Almeida Sampaio; Eufrázio de Souza Santos; Ana Cristina de Souza Bezerra
Journal:  Rev Bras Hematol Hemoter       Date:  2012

6.  Association of blood pressure and hypertension with alcohol consumption in HIV-infected white and nonwhite patients.

Authors:  Maria Leticia R Ikeda; Nêmora T Barcellos; Paulo R Alencastro; Fernando H Wolff; Ajácio B M Brandão; Flávio D Fuchs; Sandra C Fuchs
Journal:  ScientificWorldJournal       Date:  2013-10-21

7.  SOFA in the first 24 hours as an outcome predictor of acute liver failure.

Authors:  Edison Moraes Rodrigues-Filho; Rogério Fernandes; Anderson Garcez
Journal:  Rev Bras Ter Intensiva       Date:  2018-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.